nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—type 2 diabetes mellitus—atherosclerosis	0.438	1	CtDrD
Repaglinide—PPARG—atherosclerosis	0.156	0.727	CbGaD
Repaglinide—ALB—atherosclerosis	0.0586	0.273	CbGaD
Repaglinide—SLCO1B1—Rosuvastatin—atherosclerosis	0.0338	0.137	CbGbCtD
Repaglinide—SLCO1B1—Ezetimibe—atherosclerosis	0.0338	0.137	CbGbCtD
Repaglinide—SLCO1B1—Simvastatin—atherosclerosis	0.0314	0.128	CbGbCtD
Repaglinide—SLCO1B1—Lovastatin—atherosclerosis	0.0307	0.125	CbGbCtD
Repaglinide—SLCO1B1—Pravastatin—atherosclerosis	0.0307	0.125	CbGbCtD
Repaglinide—ALB—Rosuvastatin—atherosclerosis	0.0185	0.0753	CbGbCtD
Repaglinide—CYP2C8—Simvastatin—atherosclerosis	0.0133	0.0541	CbGbCtD
Repaglinide—CYP2C8—Lovastatin—atherosclerosis	0.013	0.0529	CbGbCtD
Repaglinide—CYP2C8—Pravastatin—atherosclerosis	0.013	0.0529	CbGbCtD
Repaglinide—CYP3A4—Ezetimibe—atherosclerosis	0.00579	0.0236	CbGbCtD
Repaglinide—CYP3A4—Rosuvastatin—atherosclerosis	0.00579	0.0236	CbGbCtD
Repaglinide—CYP3A4—Simvastatin—atherosclerosis	0.00539	0.0219	CbGbCtD
Repaglinide—CYP3A4—Lovastatin—atherosclerosis	0.00527	0.0215	CbGbCtD
Repaglinide—CYP3A4—Pravastatin—atherosclerosis	0.00527	0.0215	CbGbCtD
Repaglinide—ABCC8—penis—atherosclerosis	0.0029	0.214	CbGeAlD
Repaglinide—PPARG—leg—atherosclerosis	0.00187	0.138	CbGeAlD
Repaglinide—PPARG—hindlimb—atherosclerosis	0.00167	0.123	CbGeAlD
Repaglinide—PPARG—appendage—atherosclerosis	0.00143	0.106	CbGeAlD
Repaglinide—PPARG—artery—atherosclerosis	0.00102	0.0757	CbGeAlD
Repaglinide—PPARG—endothelium—atherosclerosis	0.000864	0.0639	CbGeAlD
Repaglinide—PPARG—blood vessel—atherosclerosis	0.000797	0.0589	CbGeAlD
Repaglinide—Hepatic enzyme increased—Rosuvastatin—atherosclerosis	0.000766	0.0161	CcSEcCtD
Repaglinide—Vasculitis—Lovastatin—atherosclerosis	0.000629	0.0132	CcSEcCtD
Repaglinide—Vasculitis—Ezetimibe—atherosclerosis	0.000617	0.013	CcSEcCtD
Repaglinide—Vasculitis—Simvastatin—atherosclerosis	0.000589	0.0124	CcSEcCtD
Repaglinide—Vasculitis—Pravastatin—atherosclerosis	0.000532	0.0112	CcSEcCtD
Repaglinide—Hepatic function abnormal—Lovastatin—atherosclerosis	0.00051	0.0107	CcSEcCtD
Repaglinide—KCNJ11—cardiovascular system—atherosclerosis	0.000506	0.0374	CbGeAlD
Repaglinide—Haemolytic anaemia—Lovastatin—atherosclerosis	0.000494	0.0104	CcSEcCtD
Repaglinide—Hepatic function abnormal—Simvastatin—atherosclerosis	0.000477	0.01	CcSEcCtD
Repaglinide—ABCC8—cardiovascular system—atherosclerosis	0.000466	0.0344	CbGeAlD
Repaglinide—Haemolytic anaemia—Simvastatin—atherosclerosis	0.000462	0.0097	CcSEcCtD
Repaglinide—Pancreatitis—Rosuvastatin—atherosclerosis	0.000446	0.00936	CcSEcCtD
Repaglinide—Hepatic function abnormal—Niacin—atherosclerosis	0.000438	0.0092	CcSEcCtD
Repaglinide—Bronchitis—Rosuvastatin—atherosclerosis	0.000437	0.00918	CcSEcCtD
Repaglinide—Hepatic function abnormal—Pravastatin—atherosclerosis	0.000431	0.00906	CcSEcCtD
Repaglinide—Haemolytic anaemia—Pravastatin—atherosclerosis	0.000418	0.00877	CcSEcCtD
Repaglinide—PPARG—connective tissue—atherosclerosis	0.000409	0.0302	CbGeAlD
Repaglinide—Jaundice—Rosuvastatin—atherosclerosis	0.000395	0.0083	CcSEcCtD
Repaglinide—Urinary tract infection—Rosuvastatin—atherosclerosis	0.000394	0.00827	CcSEcCtD
Repaglinide—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.000383	0.00805	CcSEcCtD
Repaglinide—Sinusitis—Rosuvastatin—atherosclerosis	0.00038	0.00798	CcSEcCtD
Repaglinide—Pancreatitis—Lovastatin—atherosclerosis	0.000378	0.00793	CcSEcCtD
Repaglinide—Pancreatitis—Ezetimibe—atherosclerosis	0.000371	0.00778	CcSEcCtD
Repaglinide—Rhinitis—Rosuvastatin—atherosclerosis	0.000365	0.00766	CcSEcCtD
Repaglinide—Hepatitis—Rosuvastatin—atherosclerosis	0.000364	0.00764	CcSEcCtD
Repaglinide—PPARG—cardiovascular system—atherosclerosis	0.000356	0.0263	CbGeAlD
Repaglinide—Pancreatitis—Simvastatin—atherosclerosis	0.000353	0.00742	CcSEcCtD
Repaglinide—Bronchitis—Simvastatin—atherosclerosis	0.000347	0.00728	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000341	0.00715	CcSEcCtD
Repaglinide—Urinary tract infection—Lovastatin—atherosclerosis	0.000334	0.00701	CcSEcCtD
Repaglinide—Jaundice—Ezetimibe—atherosclerosis	0.000329	0.0069	CcSEcCtD
Repaglinide—Arrhythmia—Rosuvastatin—atherosclerosis	0.000325	0.00682	CcSEcCtD
Repaglinide—Angina pectoris—Niacin—atherosclerosis	0.000322	0.00677	CcSEcCtD
Repaglinide—Sinusitis—Lovastatin—atherosclerosis	0.000322	0.00677	CcSEcCtD
Repaglinide—Pancreatitis—Pravastatin—atherosclerosis	0.00032	0.00671	CcSEcCtD
Repaglinide—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000319	0.00669	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000319	0.00669	CcSEcCtD
Repaglinide—Bronchitis—Niacin—atherosclerosis	0.000318	0.00668	CcSEcCtD
Repaglinide—Angina pectoris—Pravastatin—atherosclerosis	0.000317	0.00666	CcSEcCtD
Repaglinide—Sinusitis—Ezetimibe—atherosclerosis	0.000316	0.00664	CcSEcCtD
Repaglinide—PPARG—adipose tissue—atherosclerosis	0.000314	0.0232	CbGeAlD
Repaglinide—Jaundice—Simvastatin—atherosclerosis	0.000313	0.00658	CcSEcCtD
Repaglinide—Hepatitis—Lovastatin—atherosclerosis	0.000308	0.00647	CcSEcCtD
Repaglinide—Hepatitis—Ezetimibe—atherosclerosis	0.000303	0.00635	CcSEcCtD
Repaglinide—Sinusitis—Simvastatin—atherosclerosis	0.000302	0.00633	CcSEcCtD
Repaglinide—Oedema peripheral—Ezetimibe—atherosclerosis	0.000298	0.00626	CcSEcCtD
Repaglinide—Erythema multiforme—Lovastatin—atherosclerosis	0.000292	0.00612	CcSEcCtD
Repaglinide—Hepatitis—Simvastatin—atherosclerosis	0.000289	0.00606	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000288	0.00605	CcSEcCtD
Repaglinide—Jaundice—Niacin—atherosclerosis	0.000288	0.00604	CcSEcCtD
Repaglinide—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000286	0.00601	CcSEcCtD
Repaglinide—Erythema multiforme—Ezetimibe—atherosclerosis	0.000286	0.006	CcSEcCtD
Repaglinide—Myocardial infarction—Pravastatin—atherosclerosis	0.000285	0.00598	CcSEcCtD
Repaglinide—Jaundice—Pravastatin—atherosclerosis	0.000283	0.00594	CcSEcCtD
Repaglinide—Urinary tract infection—Pravastatin—atherosclerosis	0.000282	0.00593	CcSEcCtD
Repaglinide—Immune system disorder—Ezetimibe—atherosclerosis	0.000273	0.00574	CcSEcCtD
Repaglinide—Erythema multiforme—Simvastatin—atherosclerosis	0.000273	0.00573	CcSEcCtD
Repaglinide—Sinusitis—Pravastatin—atherosclerosis	0.000273	0.00572	CcSEcCtD
Repaglinide—Alopecia—Lovastatin—atherosclerosis	0.000273	0.00572	CcSEcCtD
Repaglinide—Arthralgia—Rosuvastatin—atherosclerosis	0.00027	0.00566	CcSEcCtD
Repaglinide—Alopecia—Ezetimibe—atherosclerosis	0.000267	0.00561	CcSEcCtD
Repaglinide—Rhinitis—Niacin—atherosclerosis	0.000266	0.00557	CcSEcCtD
Repaglinide—Hepatitis—Niacin—atherosclerosis	0.000265	0.00556	CcSEcCtD
Repaglinide—Erythema—Ezetimibe—atherosclerosis	0.000263	0.00553	CcSEcCtD
Repaglinide—Malnutrition—Ezetimibe—atherosclerosis	0.000263	0.00553	CcSEcCtD
Repaglinide—Rhinitis—Pravastatin—atherosclerosis	0.000262	0.00549	CcSEcCtD
Repaglinide—Oedema peripheral—Niacin—atherosclerosis	0.000261	0.00548	CcSEcCtD
Repaglinide—Hepatitis—Pravastatin—atherosclerosis	0.000261	0.00548	CcSEcCtD
Repaglinide—Back pain—Lovastatin—atherosclerosis	0.00026	0.00545	CcSEcCtD
Repaglinide—Visual impairment—Niacin—atherosclerosis	0.000255	0.00536	CcSEcCtD
Repaglinide—Alopecia—Simvastatin—atherosclerosis	0.000255	0.00535	CcSEcCtD
Repaglinide—SLCO1B1—liver—atherosclerosis	0.000255	0.0189	CbGeAlD
Repaglinide—Back pain—Ezetimibe—atherosclerosis	0.000255	0.00535	CcSEcCtD
Repaglinide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000253	0.00531	CcSEcCtD
Repaglinide—Visual impairment—Pravastatin—atherosclerosis	0.000251	0.00528	CcSEcCtD
Repaglinide—Erythema—Simvastatin—atherosclerosis	0.000251	0.00527	CcSEcCtD
Repaglinide—Eye disorder—Niacin—atherosclerosis	0.000248	0.0052	CcSEcCtD
Repaglinide—Erythema multiforme—Pravastatin—atherosclerosis	0.000247	0.00518	CcSEcCtD
Repaglinide—Cardiac disorder—Pravastatin—atherosclerosis	0.000242	0.00508	CcSEcCtD
Repaglinide—Leukopenia—Lovastatin—atherosclerosis	0.00024	0.00504	CcSEcCtD
Repaglinide—Arrhythmia—Niacin—atherosclerosis	0.000237	0.00497	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000236	0.00495	CcSEcCtD
Repaglinide—Alopecia—Niacin—atherosclerosis	0.000234	0.00491	CcSEcCtD
Repaglinide—Arrhythmia—Pravastatin—atherosclerosis	0.000233	0.00489	CcSEcCtD
Repaglinide—Palpitations—Ezetimibe—atherosclerosis	0.000233	0.00489	CcSEcCtD
Repaglinide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000232	0.00487	CcSEcCtD
Repaglinide—Erythema—Niacin—atherosclerosis	0.000231	0.00484	CcSEcCtD
Repaglinide—Malnutrition—Niacin—atherosclerosis	0.000231	0.00484	CcSEcCtD
Repaglinide—Alopecia—Pravastatin—atherosclerosis	0.00023	0.00484	CcSEcCtD
Repaglinide—Chest pain—Lovastatin—atherosclerosis	0.000229	0.0048	CcSEcCtD
Repaglinide—Arthralgia—Lovastatin—atherosclerosis	0.000229	0.0048	CcSEcCtD
Repaglinide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000228	0.00478	CcSEcCtD
Repaglinide—Hypertension—Ezetimibe—atherosclerosis	0.000227	0.00477	CcSEcCtD
Repaglinide—Leukopenia—Simvastatin—atherosclerosis	0.000225	0.00472	CcSEcCtD
Repaglinide—Arthralgia—Ezetimibe—atherosclerosis	0.000224	0.00471	CcSEcCtD
Repaglinide—Chest pain—Ezetimibe—atherosclerosis	0.000224	0.00471	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000223	0.00467	CcSEcCtD
Repaglinide—Constipation—Rosuvastatin—atherosclerosis	0.000221	0.00464	CcSEcCtD
Repaglinide—PPARG—liver—atherosclerosis	0.00022	0.0163	CbGeAlD
Repaglinide—Anaphylactic shock—Lovastatin—atherosclerosis	0.000219	0.0046	CcSEcCtD
Repaglinide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000215	0.00451	CcSEcCtD
Repaglinide—Thrombocytopenia—Lovastatin—atherosclerosis	0.000215	0.0045	CcSEcCtD
Repaglinide—Chest pain—Simvastatin—atherosclerosis	0.000214	0.00449	CcSEcCtD
Repaglinide—Arthralgia—Simvastatin—atherosclerosis	0.000214	0.00449	CcSEcCtD
Repaglinide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000211	0.00444	CcSEcCtD
Repaglinide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00021	0.00442	CcSEcCtD
Repaglinide—Skin disorder—Ezetimibe—atherosclerosis	0.000209	0.00438	CcSEcCtD
Repaglinide—Leukopenia—Niacin—atherosclerosis	0.000206	0.00433	CcSEcCtD
Repaglinide—ALB—liver—atherosclerosis	0.000206	0.0153	CbGeAlD
Repaglinide—Urticaria—Rosuvastatin—atherosclerosis	0.000205	0.00431	CcSEcCtD
Repaglinide—Anaphylactic shock—Simvastatin—atherosclerosis	0.000205	0.0043	CcSEcCtD
Repaglinide—Oedema—Simvastatin—atherosclerosis	0.000205	0.0043	CcSEcCtD
Repaglinide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000204	0.00429	CcSEcCtD
Repaglinide—Palpitations—Niacin—atherosclerosis	0.000204	0.00428	CcSEcCtD
Repaglinide—Leukopenia—Pravastatin—atherosclerosis	0.000203	0.00427	CcSEcCtD
Repaglinide—Thrombocytopenia—Simvastatin—atherosclerosis	0.000201	0.00421	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.0002	0.00419	CcSEcCtD
Repaglinide—Paraesthesia—Lovastatin—atherosclerosis	0.000197	0.00413	CcSEcCtD
Repaglinide—Arthralgia—Niacin—atherosclerosis	0.000196	0.00412	CcSEcCtD
Repaglinide—Hypertension—Pravastatin—atherosclerosis	0.000196	0.00411	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000196	0.00411	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000195	0.00409	CcSEcCtD
Repaglinide—Arthralgia—Pravastatin—atherosclerosis	0.000193	0.00406	CcSEcCtD
Repaglinide—Chest pain—Pravastatin—atherosclerosis	0.000193	0.00406	CcSEcCtD
Repaglinide—Paraesthesia—Ezetimibe—atherosclerosis	0.000193	0.00405	CcSEcCtD
Repaglinide—Dyspepsia—Lovastatin—atherosclerosis	0.000193	0.00405	CcSEcCtD
Repaglinide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000191	0.004	CcSEcCtD
Repaglinide—Dyspepsia—Ezetimibe—atherosclerosis	0.000189	0.00397	CcSEcCtD
Repaglinide—Anaphylactic shock—Niacin—atherosclerosis	0.000188	0.00395	CcSEcCtD
Repaglinide—Oedema—Niacin—atherosclerosis	0.000188	0.00395	CcSEcCtD
Repaglinide—Constipation—Lovastatin—atherosclerosis	0.000187	0.00393	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000187	0.00392	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000186	0.0039	CcSEcCtD
Repaglinide—Anaphylactic shock—Pravastatin—atherosclerosis	0.000185	0.00389	CcSEcCtD
Repaglinide—Oedema—Pravastatin—atherosclerosis	0.000185	0.00389	CcSEcCtD
Repaglinide—Paraesthesia—Simvastatin—atherosclerosis	0.000184	0.00386	CcSEcCtD
Repaglinide—Constipation—Ezetimibe—atherosclerosis	0.000184	0.00386	CcSEcCtD
Repaglinide—Pruritus—Rosuvastatin—atherosclerosis	0.000183	0.00384	CcSEcCtD
Repaglinide—Skin disorder—Niacin—atherosclerosis	0.000183	0.00384	CcSEcCtD
Repaglinide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000181	0.00381	CcSEcCtD
Repaglinide—Dyspepsia—Simvastatin—atherosclerosis	0.00018	0.00379	CcSEcCtD
Repaglinide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000179	0.00376	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000177	0.00371	CcSEcCtD
Repaglinide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000177	0.00371	CcSEcCtD
Repaglinide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000176	0.00369	CcSEcCtD
Repaglinide—Constipation—Simvastatin—atherosclerosis	0.000175	0.00368	CcSEcCtD
Repaglinide—Urticaria—Lovastatin—atherosclerosis	0.000174	0.00365	CcSEcCtD
Repaglinide—Abdominal pain—Lovastatin—atherosclerosis	0.000173	0.00364	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000171	0.0036	CcSEcCtD
Repaglinide—Urticaria—Ezetimibe—atherosclerosis	0.000171	0.00358	CcSEcCtD
Repaglinide—Abdominal pain—Ezetimibe—atherosclerosis	0.00017	0.00357	CcSEcCtD
Repaglinide—Paraesthesia—Niacin—atherosclerosis	0.000169	0.00355	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000169	0.00354	CcSEcCtD
Repaglinide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000168	0.00352	CcSEcCtD
Repaglinide—Paraesthesia—Pravastatin—atherosclerosis	0.000166	0.00349	CcSEcCtD
Repaglinide—Dyspepsia—Niacin—atherosclerosis	0.000166	0.00348	CcSEcCtD
Repaglinide—Dyspepsia—Pravastatin—atherosclerosis	0.000163	0.00342	CcSEcCtD
Repaglinide—Rash—Rosuvastatin—atherosclerosis	0.000163	0.00342	CcSEcCtD
Repaglinide—Dermatitis—Rosuvastatin—atherosclerosis	0.000163	0.00342	CcSEcCtD
Repaglinide—Urticaria—Simvastatin—atherosclerosis	0.000163	0.00342	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000162	0.00341	CcSEcCtD
Repaglinide—Abdominal pain—Simvastatin—atherosclerosis	0.000162	0.0034	CcSEcCtD
Repaglinide—Headache—Rosuvastatin—atherosclerosis	0.000162	0.0034	CcSEcCtD
Repaglinide—Hypersensitivity—Lovastatin—atherosclerosis	0.000161	0.00339	CcSEcCtD
Repaglinide—Constipation—Pravastatin—atherosclerosis	0.000158	0.00333	CcSEcCtD
Repaglinide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000158	0.00332	CcSEcCtD
Repaglinide—Pruritus—Lovastatin—atherosclerosis	0.000155	0.00325	CcSEcCtD
Repaglinide—Gastrointestinal pain—Niacin—atherosclerosis	0.000154	0.00323	CcSEcCtD
Repaglinide—Nausea—Rosuvastatin—atherosclerosis	0.000154	0.00322	CcSEcCtD
Repaglinide—Pruritus—Ezetimibe—atherosclerosis	0.000152	0.00319	CcSEcCtD
Repaglinide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000152	0.00318	CcSEcCtD
Repaglinide—Hypersensitivity—Simvastatin—atherosclerosis	0.000151	0.00317	CcSEcCtD
Repaglinide—Diarrhoea—Lovastatin—atherosclerosis	0.00015	0.00315	CcSEcCtD
Repaglinide—Urticaria—Niacin—atherosclerosis	0.00015	0.00314	CcSEcCtD
Repaglinide—Abdominal pain—Niacin—atherosclerosis	0.000149	0.00312	CcSEcCtD
Repaglinide—Urticaria—Pravastatin—atherosclerosis	0.000147	0.00309	CcSEcCtD
Repaglinide—Diarrhoea—Ezetimibe—atherosclerosis	0.000147	0.00309	CcSEcCtD
Repaglinide—Abdominal pain—Pravastatin—atherosclerosis	0.000146	0.00307	CcSEcCtD
Repaglinide—Pruritus—Simvastatin—atherosclerosis	0.000145	0.00304	CcSEcCtD
Repaglinide—CYP2C8—liver—atherosclerosis	0.000145	0.0107	CbGeAlD
Repaglinide—Diarrhoea—Simvastatin—atherosclerosis	0.00014	0.00294	CcSEcCtD
Repaglinide—Vomiting—Lovastatin—atherosclerosis	0.000139	0.00292	CcSEcCtD
Repaglinide—Hypersensitivity—Niacin—atherosclerosis	0.000139	0.00291	CcSEcCtD
Repaglinide—Rash—Lovastatin—atherosclerosis	0.000138	0.0029	CcSEcCtD
Repaglinide—Dermatitis—Lovastatin—atherosclerosis	0.000138	0.0029	CcSEcCtD
Repaglinide—Headache—Lovastatin—atherosclerosis	0.000137	0.00288	CcSEcCtD
Repaglinide—Vomiting—Ezetimibe—atherosclerosis	0.000137	0.00287	CcSEcCtD
Repaglinide—Hypersensitivity—Pravastatin—atherosclerosis	0.000137	0.00287	CcSEcCtD
Repaglinide—Rash—Ezetimibe—atherosclerosis	0.000136	0.00284	CcSEcCtD
Repaglinide—Dermatitis—Ezetimibe—atherosclerosis	0.000135	0.00284	CcSEcCtD
Repaglinide—Headache—Ezetimibe—atherosclerosis	0.000135	0.00283	CcSEcCtD
Repaglinide—Pruritus—Niacin—atherosclerosis	0.000133	0.0028	CcSEcCtD
Repaglinide—Pruritus—Pravastatin—atherosclerosis	0.000131	0.00275	CcSEcCtD
Repaglinide—Vomiting—Simvastatin—atherosclerosis	0.00013	0.00274	CcSEcCtD
Repaglinide—Nausea—Lovastatin—atherosclerosis	0.00013	0.00273	CcSEcCtD
Repaglinide—Rash—Simvastatin—atherosclerosis	0.000129	0.00271	CcSEcCtD
Repaglinide—Dermatitis—Simvastatin—atherosclerosis	0.000129	0.00271	CcSEcCtD
Repaglinide—Diarrhoea—Niacin—atherosclerosis	0.000129	0.0027	CcSEcCtD
Repaglinide—Headache—Simvastatin—atherosclerosis	0.000128	0.0027	CcSEcCtD
Repaglinide—Nausea—Ezetimibe—atherosclerosis	0.000128	0.00268	CcSEcCtD
Repaglinide—Diarrhoea—Pravastatin—atherosclerosis	0.000127	0.00266	CcSEcCtD
Repaglinide—Nausea—Simvastatin—atherosclerosis	0.000122	0.00256	CcSEcCtD
Repaglinide—Vomiting—Niacin—atherosclerosis	0.00012	0.00251	CcSEcCtD
Repaglinide—Rash—Niacin—atherosclerosis	0.000119	0.00249	CcSEcCtD
Repaglinide—Dermatitis—Niacin—atherosclerosis	0.000119	0.00249	CcSEcCtD
Repaglinide—Headache—Niacin—atherosclerosis	0.000118	0.00247	CcSEcCtD
Repaglinide—Vomiting—Pravastatin—atherosclerosis	0.000118	0.00247	CcSEcCtD
Repaglinide—Rash—Pravastatin—atherosclerosis	0.000117	0.00245	CcSEcCtD
Repaglinide—Dermatitis—Pravastatin—atherosclerosis	0.000117	0.00245	CcSEcCtD
Repaglinide—Headache—Pravastatin—atherosclerosis	0.000116	0.00244	CcSEcCtD
Repaglinide—Nausea—Niacin—atherosclerosis	0.000112	0.00235	CcSEcCtD
Repaglinide—Nausea—Pravastatin—atherosclerosis	0.00011	0.00231	CcSEcCtD
Repaglinide—CYP3A4—liver—atherosclerosis	9.82e-05	0.00726	CbGeAlD
Repaglinide—KCNJ11—Metabolism—AGT—atherosclerosis	7.94e-06	0.000193	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—APOA1—atherosclerosis	7.93e-06	0.000193	CbGpPWpGaD
Repaglinide—ALB—Metabolism—LCAT—atherosclerosis	7.9e-06	0.000192	CbGpPWpGaD
Repaglinide—ALB—Metabolism—FABP4—atherosclerosis	7.9e-06	0.000192	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—PLG—atherosclerosis	7.8e-06	0.00019	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—VEGFA—atherosclerosis	7.8e-06	0.00019	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOA4—atherosclerosis	7.79e-06	0.00019	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—PPARA—atherosclerosis	7.79e-06	0.00019	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—APOE—atherosclerosis	7.78e-06	0.000189	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOA4—atherosclerosis	7.75e-06	0.000189	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—STAT3—atherosclerosis	7.72e-06	0.000188	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—HMGCR—atherosclerosis	7.72e-06	0.000188	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—CAV1—atherosclerosis	7.71e-06	0.000188	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—APOA1—atherosclerosis	7.69e-06	0.000187	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP7A1—atherosclerosis	7.66e-06	0.000186	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP7A1—atherosclerosis	7.61e-06	0.000185	CbGpPWpGaD
Repaglinide—SLCO1B1—Transmembrane transport of small molecules—ALB—atherosclerosis	7.57e-06	0.000184	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—HMOX1—atherosclerosis	7.5e-06	0.000183	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PRKCG—atherosclerosis	7.4e-06	0.00018	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—MAPK3—atherosclerosis	7.38e-06	0.00018	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	7.3e-06	0.000178	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	7.26e-06	0.000177	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CG—atherosclerosis	7.24e-06	0.000176	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CD36—atherosclerosis	7.23e-06	0.000176	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—HMOX1—atherosclerosis	7.2e-06	0.000175	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APOB—atherosclerosis	7.18e-06	0.000175	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TGFB1—atherosclerosis	7.16e-06	0.000174	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP27A1—atherosclerosis	7.08e-06	0.000172	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—ESR1—atherosclerosis	7.06e-06	0.000172	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP27A1—atherosclerosis	7.04e-06	0.000171	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	7.03e-06	0.000171	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CG—atherosclerosis	7.02e-06	0.000171	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GSTM1—atherosclerosis	6.99e-06	0.00017	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PPARG—atherosclerosis	6.99e-06	0.00017	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.97e-06	0.00017	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.96e-06	0.00017	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.93e-06	0.000169	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—APOB—atherosclerosis	6.9e-06	0.000168	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ABCA1—atherosclerosis	6.88e-06	0.000168	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—LPL—atherosclerosis	6.86e-06	0.000167	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—INS—atherosclerosis	6.85e-06	0.000167	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.8e-06	0.000165	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PPARG—atherosclerosis	6.77e-06	0.000165	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.76e-06	0.000165	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALOX15—atherosclerosis	6.71e-06	0.000163	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	6.71e-06	0.000163	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOA2—atherosclerosis	6.71e-06	0.000163	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	6.71e-06	0.000163	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—GPX1—atherosclerosis	6.69e-06	0.000163	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—TNF—atherosclerosis	6.69e-06	0.000163	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—atherosclerosis	6.68e-06	0.000163	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOA2—atherosclerosis	6.67e-06	0.000162	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PLA2G2A—atherosclerosis	6.67e-06	0.000162	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALOX5AP—atherosclerosis	6.67e-06	0.000162	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALOX15—atherosclerosis	6.67e-06	0.000162	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PDGFB—atherosclerosis	6.67e-06	0.000162	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—INS—atherosclerosis	6.64e-06	0.000162	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCG5—atherosclerosis	6.63e-06	0.000161	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.62e-06	0.000161	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLTP—atherosclerosis	6.61e-06	0.000161	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MMP1—atherosclerosis	6.59e-06	0.00016	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCG5—atherosclerosis	6.59e-06	0.00016	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.58e-06	0.00016	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CD36—atherosclerosis	6.52e-06	0.000159	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—LPA—atherosclerosis	6.4e-06	0.000156	CbGpPWpGaD
Repaglinide—ALB—Metabolism—LPA—atherosclerosis	6.36e-06	0.000155	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—CAV1—atherosclerosis	6.32e-06	0.000154	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	6.32e-06	0.000154	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—APOA1—atherosclerosis	6.31e-06	0.000153	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—ALB—atherosclerosis	6.28e-06	0.000153	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—BGN—atherosclerosis	6.2e-06	0.000151	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—MTHFR—atherosclerosis	6.17e-06	0.00015	CbGpPWpGaD
Repaglinide—ALB—Metabolism—BGN—atherosclerosis	6.16e-06	0.00015	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.15e-06	0.00015	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOA5—atherosclerosis	6.14e-06	0.000149	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	6.13e-06	0.000149	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.12e-06	0.000149	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOA5—atherosclerosis	6.1e-06	0.000149	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—ALB—atherosclerosis	6.09e-06	0.000148	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PPARA—atherosclerosis	6.06e-06	0.000147	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—F2—atherosclerosis	6.02e-06	0.000146	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—NOS3—atherosclerosis	6.01e-06	0.000146	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.96e-06	0.000145	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS2—atherosclerosis	5.94e-06	0.000145	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.93e-06	0.000144	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	5.91e-06	0.000144	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—HMOX1—atherosclerosis	5.9e-06	0.000144	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PLA2G1B—atherosclerosis	5.87e-06	0.000143	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AGT—atherosclerosis	5.87e-06	0.000143	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.84e-06	0.000142	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—NOS3—atherosclerosis	5.83e-06	0.000142	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	5.82e-06	0.000142	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.81e-06	0.000141	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—SERPINE1—atherosclerosis	5.8e-06	0.000141	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.79e-06	0.000141	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.77e-06	0.000141	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CG—atherosclerosis	5.76e-06	0.00014	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.75e-06	0.00014	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APOE—atherosclerosis	5.75e-06	0.00014	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.74e-06	0.00014	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCG8—atherosclerosis	5.73e-06	0.00014	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LTA4H—atherosclerosis	5.73e-06	0.00014	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALOX5—atherosclerosis	5.71e-06	0.000139	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—CAV1—atherosclerosis	5.7e-06	0.000139	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—APOA1—atherosclerosis	5.68e-06	0.000138	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ALOX5—atherosclerosis	5.67e-06	0.000138	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOB—atherosclerosis	5.66e-06	0.000138	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GSTM1—atherosclerosis	5.5e-06	0.000134	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PTGS2—atherosclerosis	5.5e-06	0.000134	CbGpPWpGaD
Repaglinide—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	5.46e-06	0.000133	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—LPL—atherosclerosis	5.4e-06	0.000131	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—IL6—atherosclerosis	5.4e-06	0.000131	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PTGS2—atherosclerosis	5.33e-06	0.00013	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.27e-06	0.000128	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—IGF1—atherosclerosis	5.27e-06	0.000128	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—GPX1—atherosclerosis	5.27e-06	0.000128	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.24e-06	0.000128	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CG—atherosclerosis	5.19e-06	0.000126	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CD36—atherosclerosis	5.13e-06	0.000125	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NAMPT—atherosclerosis	5.12e-06	0.000125	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NAMPT—atherosclerosis	5.09e-06	0.000124	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.09e-06	0.000124	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—LIPC—atherosclerosis	5.08e-06	0.000124	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.06e-06	0.000123	CbGpPWpGaD
Repaglinide—ALB—Metabolism—LIPC—atherosclerosis	5.06e-06	0.000123	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOC3—atherosclerosis	5.05e-06	0.000123	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOC3—atherosclerosis	5.02e-06	0.000122	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—LDLR—atherosclerosis	5.02e-06	0.000122	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SERPINE1—atherosclerosis	5.01e-06	0.000122	CbGpPWpGaD
Repaglinide—ALB—Metabolism—LDLR—atherosclerosis	4.99e-06	0.000122	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—AKT1—atherosclerosis	4.98e-06	0.000121	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—INS—atherosclerosis	4.91e-06	0.00012	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CETP—atherosclerosis	4.91e-06	0.000119	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CETP—atherosclerosis	4.88e-06	0.000119	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—MTHFR—atherosclerosis	4.86e-06	0.000118	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS3—atherosclerosis	4.78e-06	0.000116	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPARA—atherosclerosis	4.77e-06	0.000116	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SCARB1—atherosclerosis	4.7e-06	0.000114	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SCARB1—atherosclerosis	4.67e-06	0.000114	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AGT—atherosclerosis	4.62e-06	0.000112	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.57e-06	0.000111	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCG1—atherosclerosis	4.53e-06	0.00011	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOE—atherosclerosis	4.53e-06	0.00011	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALB—atherosclerosis	4.5e-06	0.00011	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CAV1—atherosclerosis	4.48e-06	0.000109	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOA1—atherosclerosis	4.47e-06	0.000109	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HMGCR—atherosclerosis	4.44e-06	0.000108	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HMGCR—atherosclerosis	4.41e-06	0.000107	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—NOS3—atherosclerosis	4.31e-06	0.000105	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—FABP4—atherosclerosis	4.26e-06	0.000104	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LCAT—atherosclerosis	4.26e-06	0.000104	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	4.26e-06	0.000104	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOA4—atherosclerosis	4.18e-06	0.000102	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	4.11e-06	0.0001	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	4.09e-06	9.94e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4e-06	9.74e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.98e-06	9.69e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ABCA1—atherosclerosis	3.95e-06	9.63e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPARG—atherosclerosis	3.94e-06	9.6e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—atherosclerosis	3.94e-06	9.59e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—ABCA1—atherosclerosis	3.93e-06	9.57e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—INS—atherosclerosis	3.87e-06	9.41e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.8e-06	9.25e-05	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MAPK3—atherosclerosis	3.77e-06	9.19e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOA2—atherosclerosis	3.6e-06	8.77e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.6e-06	8.77e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.6e-06	8.77e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.6e-06	8.77e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.56e-06	8.66e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALB—atherosclerosis	3.55e-06	8.63e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—VEGFA—atherosclerosis	3.44e-06	8.38e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LPA—atherosclerosis	3.44e-06	8.36e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HMOX1—atherosclerosis	3.39e-06	8.26e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—NOS3—atherosclerosis	3.39e-06	8.25e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HMOX1—atherosclerosis	3.37e-06	8.21e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—BGN—atherosclerosis	3.33e-06	8.1e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOA5—atherosclerosis	3.29e-06	8.02e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—MAPK3—atherosclerosis	3.26e-06	7.93e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOB—atherosclerosis	3.25e-06	7.91e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOB—atherosclerosis	3.23e-06	7.87e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.17e-06	7.72e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GSTM1—atherosclerosis	3.16e-06	7.7e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TGFB1—atherosclerosis	3.16e-06	7.69e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GSTM1—atherosclerosis	3.14e-06	7.65e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—LPL—atherosclerosis	3.1e-06	7.55e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—atherosclerosis	3.1e-06	7.55e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—LPL—atherosclerosis	3.09e-06	7.51e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.06e-06	7.45e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GPX1—atherosclerosis	3.03e-06	7.37e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GPX1—atherosclerosis	3.01e-06	7.33e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CD36—atherosclerosis	2.95e-06	7.18e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CD36—atherosclerosis	2.93e-06	7.14e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—MTHFR—atherosclerosis	2.79e-06	6.8e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—MTHFR—atherosclerosis	2.78e-06	6.76e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKT1—atherosclerosis	2.76e-06	6.72e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.75e-06	6.69e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPARA—atherosclerosis	2.74e-06	6.67e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LIPC—atherosclerosis	2.73e-06	6.64e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPARA—atherosclerosis	2.73e-06	6.63e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOC3—atherosclerosis	2.71e-06	6.6e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LDLR—atherosclerosis	2.7e-06	6.56e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKT1—atherosclerosis	2.68e-06	6.52e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AGT—atherosclerosis	2.65e-06	6.46e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AGT—atherosclerosis	2.64e-06	6.43e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CETP—atherosclerosis	2.63e-06	6.41e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOE—atherosclerosis	2.6e-06	6.33e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOE—atherosclerosis	2.59e-06	6.3e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CAV1—atherosclerosis	2.58e-06	6.27e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOA1—atherosclerosis	2.57e-06	6.26e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CAV1—atherosclerosis	2.56e-06	6.24e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOA1—atherosclerosis	2.56e-06	6.22e-05	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—AKT1—atherosclerosis	2.55e-06	6.2e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.52e-06	6.14e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.38e-06	5.8e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CG—atherosclerosis	2.35e-06	5.71e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CG—atherosclerosis	2.33e-06	5.68e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPARG—atherosclerosis	2.27e-06	5.51e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPARG—atherosclerosis	2.25e-06	5.48e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—INS—atherosclerosis	2.22e-06	5.41e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—INS—atherosclerosis	2.21e-06	5.38e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT1—atherosclerosis	2.2e-06	5.35e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.12e-06	5.17e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALB—atherosclerosis	2.04e-06	4.96e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKT1—atherosclerosis	1.98e-06	4.82e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NOS3—atherosclerosis	1.95e-06	4.74e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NOS3—atherosclerosis	1.94e-06	4.72e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.82e-06	4.43e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.78e-06	4.34e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—atherosclerosis	1.77e-06	4.31e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOB—atherosclerosis	1.74e-06	4.25e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.7e-06	4.13e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LPL—atherosclerosis	1.67e-06	4.05e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPX1—atherosclerosis	1.62e-06	3.96e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CD36—atherosclerosis	1.58e-06	3.85e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKT1—atherosclerosis	1.56e-06	3.79e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.5e-06	3.65e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARA—atherosclerosis	1.47e-06	3.58e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AGT—atherosclerosis	1.42e-06	3.47e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOE—atherosclerosis	1.4e-06	3.4e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CAV1—atherosclerosis	1.38e-06	3.37e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOA1—atherosclerosis	1.38e-06	3.36e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.26e-06	3.07e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARG—atherosclerosis	1.22e-06	2.96e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—INS—atherosclerosis	1.19e-06	2.9e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALB—atherosclerosis	1.09e-06	2.66e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NOS3—atherosclerosis	1.05e-06	2.55e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—atherosclerosis	9.57e-07	2.33e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKT1—atherosclerosis	8.96e-07	2.18e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKT1—atherosclerosis	8.91e-07	2.17e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKT1—atherosclerosis	4.81e-07	1.17e-05	CbGpPWpGaD
